Goodwin Procter advised Lacerta Therapeutics on the deal. Lacerta Therapeutics announced its AAV capsid licensing and research collaboration agreement with Prevail Therapeutics. As a part of...
Goodwin Procter advised Lacerta Therapeutics on the deal. Lacerta Therapeutics announced its AAV capsid licensing and research collaboration agreement with Prevail Therapeutics. As a part of...